Michelle K. Greene

97 Lisburn Road
Belfast, NIR BT97AE, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models.

Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models.

Journal: Biomacromolecules
Published: December 10, 2025

Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.

Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.

Journal: Biomacromolecules
Published: September 05, 2024

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity.

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2024

Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages.

Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages.

Journal: International journal of pharmaceutics
Published: March 30, 2024

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 11, 2024

Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.

Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.

Journal: Molecular pharmaceutics
Published: February 09, 2024

Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020-2021.

Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020-2021.

Journal: Heliyon
Published: October 02, 2023

Carbon nanotubes activate inflammatory signalling through binding to Siglec-14.

Carbon nanotubes activate inflammatory signalling through binding to Siglec-14.

Journal: Nature nanotechnology
Published: June 14, 2023

PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration.

PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration.

Journal: Frontiers in immunology
Published: June 09, 2023

Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors.

Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2023

Modular Chemical Construction of IgG-like Mono- and Bispecific Synthetic Antibodies (SynAbs).

Modular Chemical Construction of IgG-like Mono- and Bispecific Synthetic Antibodies (SynAbs).

Journal: ACS central science
Published: December 02, 2022

Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors.

Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors.

Journal: Nanoscale
Published: September 17, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026